Role and interaction of connective tissue growth factor with transforming growth factor-β in persistent fibrosis: A mouse fibrosis model

Journal of Cellular Physiology

Volumn 181, Issue 1, 1999, Pages 153-159

  Mori, Toshifumi ^a   Kawara, Shigeru ^a   Shinozaki, Mikio ^a   Hayashi, Nobukazu ^b   Kakinuma, Takashi ^b   Igarashi, Atsuyuki ^c   Takigawa, Masaharu ^d   Nakanishi, Toru ^d   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kanto Teishin Hospital   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GRANULATION TISSUE; GROWTH REGULATION; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; SKIN FIBROSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; GROWTH SUBSTANCES; HUMANS; IMMEDIATE-EARLY PROTEINS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MITOGENS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032794692     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K     Document Type: Article

References (34)

1. Assoian RK, Komoriya A, Meyers CA, Muller DM, Sporn MB. 1983. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J Biol Chem 258:7155-7160.
2. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, and Sporn MB. 1987. Expression and secretion of type transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020-6024.
3. Beck LS, Chen TL, Hirabayashi SE, DeGuzman L, Lee WP, McFatridge LL, Xu Y, Bates RL, Ammann AJ. 1990. Accelerated healing of ulcer wounds in the rabbit ear by recombinant human transforming growth factor-β1. Growth Factors 2:273-282.
4. Bradham DM, Igarashi A, Potter RL, Grotendorst GR. 1991. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285-1294.
5. Frazier KS, Grotendorst GR. 1997. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 29:153-161.
6. Frazier K, Williams S, Kothapalli D, Kllapper H, Grotendorst GR. 1996. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107:404-411.
7. Grotendorst GR. 1997. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 8:171-179.
8. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaren R, Black C. 1994. Immunocytochemical localization and serologic detection of transforming growth factor-β1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278-288.
9. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. 1993. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637-645.
10. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, Takehara K. 1995. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105: 280-284.
11. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Manabu F, Grotendorst GR, Takehara K. 1996. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic disease. J Invest Dermatol 106:729-733.
12. Igarashi A, Hayashi N, Nashiro K, Takehara K. 1998. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J Cutan Pathol 25:729-733.
13. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kameda T, Imai E. 1993. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into rat kidney. J Clin Invest 92:2597-2601.
14. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R. 1998. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861.
15. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. 1986. Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050.
16. Kerr LD, Miller DB, Matrisian LM. 1990. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61:267-278.
17. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR. 1997. Transforming growth factor-β induces anchorage-independent growth of NRK-fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 8:61-68.
18. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. 1986. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 103:2403-2410.
19. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M. 1998. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 275:L365-L371.
20. Leof EB, Proper JA, Gouston AS, Shipley GD, DiCorleto PE, Moses HL. 1986. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83:2453-2457.
21. Lund LR, Riccio A, Andreasen PA, Nielsen LS, Kristensen P, Laiho M, Saksela O, Blasi F, Dano K. 1987. Transforming growth factor-β is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J 6:1281-1286.
22. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF. 1987. Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science 237:1333-1336.
23. Oemar BS, Luscher TF. 1997. Connective tissue growth factor: friend or foe? Arterioscler Thromb Vasc Biol 17:1483-1489.
24. Paulsson Y, Hammacher A, Heldin CH, Westermark B. 1987. Possible positive autocrine feedback in the prereplicative phase of human fibroblasts. Nature 328:715-717.
25. Quaglino DJ, Nanney LB, Ditesheim JA, Davidson JM. 1991. Transforming growth factor-β stimulates wound healing and modulates extracellular matrix gene expression in pig skin; incisional wound model. J Invest Dermatol 97:34-42.
26. Raghow R, Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. 1987. Transforming growth factor-β increases steady state levels of type procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 79:1285-1288.
27. Roberts AB, Sporn MB. 1993. Physiological actions and clinical applications of transforming growth factor-β. Growth Factors 8:1-9.
28. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS. 1986. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171.
29. Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara K. 1997. Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor-β: simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 237:292-297.
30. Smith EA, LeRoy EC. 1990. A possible role for transforming growth factor-β in systemic sclerosis. J Invest Dermatol 95:125s-127s.
31. Soma Y, Grotendorst GR. 1989. TGF-β stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol 140:246-253.
32. Terrell TG, Working PK, Chow CP, Green JD. 1993. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol 343:43-67.
33. Varga J, Rosenbloom J, Jimenez SA. 1987. Transforming growth factor-β causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597-604.
34. Zugmaier G, Paik S, Wilding G, Knabbe C, Bano M, Lupu R, Deschauer B, Simpson S, Dickson RB, Lippman M. 1991. Transforming growth factor-β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 51:3590-3594.